FDA Inspection 1316190 — Perrigo New York, Inc.

Perrigo New York, Inc. — FEI 2450054

The FDA completed an inspection of Perrigo New York, Inc. on May 8, 2026 in Bronx, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 8, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bronx, NY (United States)

Citations

IDCFRDescription
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
141321 CFR 211.42(c)(5)Mfg / Processing Operations Area
354721 CFR 211.46(b)Equipment for Environmental Control
356521 CFR 211.58Buildings not maintained in good state of repair

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.